Dupont Jakob bought BOLT
December 12, 2025 · Form 4 insider transaction
Dupont Jakob bought 1,100 shares of Bolt Biotherapeutics, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,100
Price
N/A
Total value
N/A
InsiderDupont Jakob
RoleDirector
SecurityDirector Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after1,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price.; The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.